These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 32744402)
1. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study. Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402 [TBL] [Abstract][Full Text] [Related]
2. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study. Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917 [TBL] [Abstract][Full Text] [Related]
4. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study. Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978 [TBL] [Abstract][Full Text] [Related]
6. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747 [TBL] [Abstract][Full Text] [Related]
7. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study. Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206 [TBL] [Abstract][Full Text] [Related]
8. Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality. Alhakak A; Butt JH; Gerds TA; Fosbøl EL; Mogensen UM; Krøll J; Pallisgaard JL; Gislason GH; Torp-Pedersen C; Køber L; Weeke PE Diabetes Obes Metab; 2022 Mar; 24(3):499-510. PubMed ID: 34779086 [TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes. Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048 [TBL] [Abstract][Full Text] [Related]
10. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes. Xu L; Chan WM; Hui YF; Lam TH Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977 [TBL] [Abstract][Full Text] [Related]
11. Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan. Goto A; Noda M; Matsushita Y; Goto M; Kato M; Isogawa A; Takahashi Y; Kurotani K; Oba S; Nanri A; Mizoue T; Yamagishi K; Yatsuya H; Saito I; Kokubo Y; Sawada N; Inoue M; Iso H; Kadowaki T; Tsugane S; Medicine (Baltimore); 2015 May; 94(17):e785. PubMed ID: 25929925 [TBL] [Abstract][Full Text] [Related]
12. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings. Wright AK; Suarez-Ortegon MF; Read SH; Kontopantelis E; Buchan I; Emsley R; Sattar N; Ashcroft DM; Wild SH; Rutter MK Circulation; 2020 Nov; 142(20):1925-1936. PubMed ID: 33196309 [TBL] [Abstract][Full Text] [Related]
13. Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality. Li FR; Yang HL; Zhou R; Zheng JZ; Chen GC; Zou MC; Wu XX; Wu XB Diabetes Obes Metab; 2021 Jun; 23(6):1361-1370. PubMed ID: 33620747 [TBL] [Abstract][Full Text] [Related]
14. Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population-based cohort study. Bonnesen K; Pedersen L; Ehrenstein V; Sørensen HT; Lash TL; Schmidt M Pharmacoepidemiol Drug Saf; 2023 Nov; 32(11):1233-1243. PubMed ID: 37294526 [TBL] [Abstract][Full Text] [Related]
15. Association between glycated haemoglobin and the risk of chronic obstructive pulmonary disease: A prospective cohort study in UK biobank. Li M; Wan Y; Zhu Z; Luo P; Yu H; Su J; Hang D; Lu Y; Tao R; Wu M; Zhou J; Fan X Diabetes Obes Metab; 2023 Dec; 25(12):3599-3610. PubMed ID: 37643990 [TBL] [Abstract][Full Text] [Related]
16. Age-Specific Associations Between Systolic Blood Pressure and Cardiovascular Disease: A 10-Year Diabetes Mellitus Cohort Study. Wan EYF; Yu EYT; Chin WY; Wong ICK; Chan EWY; Chen S; Lam CLK J Am Heart Assoc; 2020 Jul; 9(14):e015771. PubMed ID: 32673523 [TBL] [Abstract][Full Text] [Related]
17. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults. Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949 [TBL] [Abstract][Full Text] [Related]
18. Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study. Wan EYF; Yu EYT; Chin WY; Barrett JK; Mok AHY; Lau CST; Wang Y; Wong ICK; Chan EWY; Lam CLK Diabetes Obes Metab; 2020 Oct; 22(10):1777-1788. PubMed ID: 32452623 [TBL] [Abstract][Full Text] [Related]
20. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study. Wan EY; Fung CS; Fong DY; Lam CL J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]